References
- GOLD: Global Initiative for Obstructive Lung Disease www.goldcopd.com 2013.
- Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W et al.: Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363(12):1128–1138.
- Garcia-Aymerich J, Serra Pons I, Mannino DM, Maas AK, Miller DP, Davis KJ: Lung function impairment, COPD hospitalizations and subsequent mortality. Thorax 2011; 66(7):585–590.
- Wouters EF: The burden of COPD in The Netherlands: results from the Confronting COPD survey. Respir Med 2003; 97 Suppl C:S51–59.
- Wouters EF: Economic analysis of the Confronting COPD survey: an overview of results. Respir Med 2003; 97 Suppl C:S3–14.
- Decramer M, Janssens W, Miravitlles M: Chronic obstructive pulmonary disease. Lancet 2012; 379(9823):1341–1351.
- Agusti A, Faner R: Systemic inflammation and co-morbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2012; 9(2):43–46.
- Aubas C, Bourdin A, Aubas P, Gamez AS, Halimi L, Vachier I, Malafaye N, Chanez P, Molinari N: Role of co-morbid conditions in asthma hospitalizations in the south of France. Allergy 2013; 68(5):637–643.
- Langsetmo L, Platt RW, Ernst P, Bourbeau J: Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J RespirCrit Care Med 2008; 177(4):396–401.
- Gaudreau K, Sanford CJ, Cheverie C, McClure C: The effect of a smoking ban on hospitalization rates for cardiovascular and respiratory conditions in Prince Edward IslandCanada. PLoS One 2013; 8(3):e56102.
- Baillargeon J, Wang Y, Kuo YF, Holmes HM, Sharma G: Temporal trends in hospitalization rates for older adults with chronic obstructive pulmonary disease. Am J Med 2013; 126(7):607–614.
- Walker PP, Thompson E, Crone H, Flatt G, Holton K, Hill SL, Pearson MG: Use of mortality within 30 days of a COPD hospitalization as a measure of COPD care in UK hospitals. Thorax 2013; 68(10):968–970.
- Groenewegen KH, Schols AM, Wouters EF: Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003; 124(2):459–467.
- Ai-Ping C, Lee KH, Lim TK: In-hospital and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD: a retrospective study. Chest 2005; 128(2):518–524.
- Seneff MG, Wagner DP, Wagner RP, Zimmerman JE, Knaus WA: Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995; 274(23):1852–1857.
- Johnston NW, Sears MR: Asthma exacerbations. 1: epidemiology. Thorax 200661(8):722–728.
- Rabe KF, Fabbri LM, Vogelmeier C, Kogler H, Schmidt H, Beeh KM, Glaab T: Seasonal distribution of COPD exacerbations in the Prevention of Exacerbations with Tiotropium in COPD trial. Chest 2013; 143(3):711–719.
- Bhowmik A, Seemungal TA, Donaldson GC, Wedzicha JA: Effects of exacerbations and seasonality on exhaled nitric oxide in COPD. EurRespir J 2005; 26(6):1009–1015.
- Jenkins CR, Celli B, Anderson JA, Ferguson GT, Jones PW, Vestbo J, Yates JC, Calverley PM: Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. EurRespir J 2012; 39(1):38–45.
- Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, McCormick M, Haldar K, Kebadze T, Duvoix A et al.: Acute exacerbations of chronic obstructive pulmonary disease: identification of iologic clusters and their biomarkers. Am J RespirCrit Care Med 2011; 184(6):662–671.
- Mallia P, Johnston SL: How viral infections cause exacerbation of airway diseases. Chest 2006; 130(4):1203–1210.
- Mallia P, Message SD, Gielen V, Contoli M, Gray K, Kebadze T, Aniscenko J, Laza-Stanca V, Edwards MR, Slater L et al.: Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J RespirCrit Care Med 2011; 183(6):734–742.
- Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL: Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J RespirCrit Care Med 2006; 173(10):1114–1121.
- Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake G, Celli B; BODE Collaborative Group: Co-morbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J RespirCrit Care Med 2012; 186(2):155–161.
- Suissa S, Dell'Aniello S, Ernst P: Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 2012; 67(11):957–963.
- Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, van Empel VP, Bruijnzeel PL, Rutten EP, Op ‘t Roodt J, Wouters EF, Franssen FM: Clusters of co-morbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J RespirCrit Care Med 2013; 187(7):728–735.
- Antonelli-Incalzi R, Pedone C: COPD: more than respiratory. Lancet 2008; 371(9606):26–27; author reply 28.
- Wilcock A, Crosby V, Freer S, Freemantle A, Caswell G, Seymour J: Lung cancer diagnosed following emergency admission: a mixed methods study protocol to improve understanding of patients’ characteristics, needs experiences and outcomes. BMC Palliat Care 2013; 12(1):24.